Postdoc
Postdoc of Institute of Chinese Medical Sciences, University of Macau
His main research is computer and simulation informed drug development.
He has built multiple PBPK models, including vemurafenib solid dispersions, andrographolide cyclodextrin complex, and RNA lipid nanoparticles. He participated in establishing a PBPK model for oral administration of labetalol in pregnant women.
He led the research of AI-driven design of mRNA lipid nanoparticle formulations.
He has published 9 articles indexed in the SCI
博士后，澳门大学中华医药研究院博士后研究员
主要研究方向为计算模拟技术引导的药物研发。
构建了包括维罗非尼固体分散体，穿心莲内酯环糊精复合物以及RNA脂质纳米粒的多个PBPK模型。参与建立了孕妇的口服拉贝洛尔PBPK模型。
主导了AI驱动的mRNA脂质纳米粒处方设计工作。
已发表SCI论文9篇
主要研究方向为计算模拟技术引导的药物研发。
构建了包括维罗非尼固体分散体，穿心莲内酯环糊精复合物以及RNA脂质纳米粒的多个PBPK模型。参与建立了孕妇的口服拉贝洛尔PBPK模型。
主导了AI驱动的mRNA脂质纳米粒处方设计工作。
已发表SCI论文9篇